← SynDRA
BISINDOLYLMALEIMIDE IX
SynDRA canonical compound SYN0000019 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | SIRT1 |
| Mechanism of action | PKC inhibitor |
All known targets
- SIRT1
- AKT1
- GSK3B
- LCK
- MAPK1
- MAPK11
- MAPK12
- MAPK14
- MAPK8
- PRKCA
- ROCK1
- RPS6KB1
Mechanisms of action (all sources)
- PKC inhibitor
- GSK3B INHIBITOR
- SIRT1 INHIBITOR
- MAPK8 INHIBITOR
- PRKCA INHIBITOR
- MAPK11 INHIBITOR
- MAPK14 INHIBITOR
- AKT1 INHIBITOR
- LCK INHIBITOR
- MAPK1 INHIBITOR
- RPS6KB1 INHIBITOR
- ROCK1 INHIBITOR
Cross-references
Synonyms
- Ro31-8220
- Ro-31-8220
- Ro-318220
- UNII-W9A0B5E78O
- CHEMBL6291
- W9A0B5E78O
- CHEBI:38912
- 3-{3-[4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]-1H-indol-1-yl}propyl carbamimidothioate
- 3-{3-[4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]-1H-indol-1-yl}propyl imidothiocarbamate
- CHEMBL1591531
- Carbamimidothioic acid, 3-(3-(2,5-dihydro-4-(1-methyl-1H-indol-3-yl)-2,5-dioxo-1H-pyrrol-3-yl)-1H-indol-1-yl)propyl
- bisindolymaleimide IX
- bisindolylmaleimide-ix
- Bis IX
- RefChem:917327
- Bisindolylmaleimide IX Methanesulfonate
- Ro 31-8220 (mesylate)
- Ro 31-8220 methanesulfonate;Bisindolylmaleimide IX mesylate
- BiomolKI_000033
- DSXXEELGXBCYNQ-UHFFFAOYSA-N
- DRN
- Bisindolylmaleimide 11b
- Ro?31-8220?
- ROCHE screening, 57
- BiomolKI2_000041
- BIM-9
- BSPBio_001077
- KBioGR_000417
- KBioSS_000417
- BDBM3175
- GTPL5259
- orb1685637
- SCHEMBL1567017
- SCHEMBL29370657
- KBio2_000417
- KBio2_002985
- KBio2_005553
- KBio3_000793
Look up BISINDOLYLMALEIMIDE IX in the interactive SynDRA portal →